These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5688368)

  • 1. Advantages of the professional fee.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):639-43. PubMed ID: 5688368
    [No Abstract]   [Full Text] [Related]  

  • 2. Determining the professional fee.
    Smith HA
    J Am Pharm Assoc; 1968 Dec; 8(12):646-9. PubMed ID: 5688369
    [No Abstract]   [Full Text] [Related]  

  • 3. Professional fee experiences.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):636-8 passim. PubMed ID: 5688367
    [No Abstract]   [Full Text] [Related]  

  • 4. Professional fee: renaissance or innovation?
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):628-31. PubMed ID: 5688365
    [No Abstract]   [Full Text] [Related]  

  • 5. Professional fee in pharmaceutical practice.
    Myers MJ
    J Am Pharm Assoc; 1968 Dec; 8(12):632-5. PubMed ID: 5688366
    [No Abstract]   [Full Text] [Related]  

  • 6. The professional fee--why and how?
    Myers MJ
    Am J Pharm Sci Support Public Health; 1968; 140(4):101-19. PubMed ID: 5678242
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of price, practice setting and quality of pharmaceutical services.
    Rowles B; Wertheimer AI
    Drug Intell Clin Pharm; 1976 Apr; 10(4):219-21. PubMed ID: 10236236
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible impact of government drug program on community pharmacies.
    Rucker TD
    J Am Pharm Assoc; 1971 Jun; 11(6):334-7. PubMed ID: 4940804
    [No Abstract]   [Full Text] [Related]  

  • 9. Present and projected drug system services in a highly developed HMO structure.
    Johnson RE
    Health Serv Rep; 1973 Nov; 88(9):873-7. PubMed ID: 4759561
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug prescribing and use in an American community.
    Stolley PD; Becker MH; McEvilla JD; Lasagna L; Gainor M; Sloane LM
    Ann Intern Med; 1972 Apr; 76(4):537-40. PubMed ID: 4640311
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost of dispensing in the pharmaceutical services.
    Opit LJ; Farmer RD
    Lancet; 1974 Feb; 1(7849):160-2. PubMed ID: 4129726
    [No Abstract]   [Full Text] [Related]  

  • 12. Relations between price and quality in community pharmacy.
    Jackson RA; Smith MC
    Med Care; 1974 Jan; 12(1):32-9. PubMed ID: 4811400
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists' participation in an inhaled respiratory medication program: reimbursement of professional fees.
    Murphy AL; MacKinnon NJ; Flanagan PS; Bowles SK; Sketris IS
    Ann Pharmacother; 2005 Apr; 39(4):655-61. PubMed ID: 15728330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public policy considerations in the pricing of prescription drugs in the United States.
    Rucker TD
    Int J Health Serv; 1974; 4(1):171-9. PubMed ID: 4829895
    [No Abstract]   [Full Text] [Related]  

  • 15. Projection of future pharmacy service fees using the dispensing claims in hospital and clinic outpatient pharmacies: national health insurance database between 2006 and 2012.
    Ha D; Song I; Lee EK; Shin JY
    BMC Health Serv Res; 2018 May; 18(1):327. PubMed ID: 29724220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Professional fees for clinical pharmacy services.
    Bellafiore IJ; Barletta MA; Bartillucci AJ
    J Am Pharm Assoc; 1976 Mar; 16(3):135-6. PubMed ID: 1254889
    [No Abstract]   [Full Text] [Related]  

  • 17. New member on the team.
    Miller WA; Corcella J
    Ment Hyg; 1972; 56(2):57-61. PubMed ID: 4339287
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacy benefit managers and compounding pharmacists: billing for services.
    Lees DJ
    Int J Pharm Compd; 2014; 18(1):87. PubMed ID: 24881346
    [No Abstract]   [Full Text] [Related]  

  • 19. Teaching pharmacists to provide and bill for clinical services.
    Martin S
    Am Pharm; 1990 May; NS30(5):24-6. PubMed ID: 2337018
    [No Abstract]   [Full Text] [Related]  

  • 20. The mail-order prescription drug industry.
    Wertheimer AI; Knoben JE
    Health Serv Rep; 1973 Nov; 88(9):852-6. PubMed ID: 4586284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.